Introduction
C11orf87 is a human gene located on chromosome 11 that encodes a protein of currently unknown function. The gene was initially identified during large-scale sequencing efforts aimed at annotating the human genome. Despite its designation as an open reading frame (ORF) rather than a protein with a defined role, C11orf87 has attracted scientific interest due to its expression profile and potential involvement in cellular processes.
Gene and Protein Overview
Gene Nomenclature and Identification
The gene symbol C11orf87 follows the convention used by the HUGO Gene Nomenclature Committee (HGNC) for uncharacterized human genes. The name reflects its chromosomal position (chromosome 11) and its status as an open reading frame that had not yet been assigned a distinct protein name. As research progresses, a more descriptive name may be adopted if functional insights emerge.
Protein Product and Isoforms
The primary transcript of C11orf87 generates a protein comprising 211 amino acids. Alternative splicing events have been reported that produce two additional isoforms differing in their C‑terminal sequences. None of these variants possess recognized catalytic motifs or transmembrane domains, suggesting a cytosolic or nuclear localization.
Gene Location and Structure
Chromosomal Position
C11orf87 is situated at 11p15.4, a region known for its involvement in imprinting disorders. The gene spans approximately 3.2 kilobases and is flanked by the neighboring genes SLC22A5 and GATA4, both of which have defined roles in fatty acid transport and cardiac development, respectively.
Genomic Features
The coding sequence of C11orf87 contains a single exon, indicating that the gene lacks introns in the mature mRNA. The 5′ untranslated region (UTR) is enriched in regulatory motifs that may mediate translation initiation, while the 3′ UTR contains multiple microRNA binding sites, hinting at post‑transcriptional regulation.
Expression Patterns
Transcriptional Landscape
Transcriptomic analyses across a panel of human tissues reveal that C11orf87 is expressed at low levels in most organs but shows moderate up‑regulation in testis, ovary, and certain brain regions. Its expression is comparatively low in liver and kidney, suggesting a tissue‑specific regulatory mechanism.
Cellular Context
Single‑cell RNA sequencing studies indicate that C11orf87 is detected in a subset of neuronal progenitor cells and in germ cells undergoing meiosis. In cultured human fibroblasts, the gene remains transcriptionally silent under basal conditions but is induced upon exposure to oxidative stressors.
Developmental Regulation
During embryogenesis, C11orf87 mRNA appears in the developing neural tube and in the gonadal ridge. Its expression peaks during mid‑gestation and subsequently diminishes, pointing toward a role in early development or differentiation.
Protein Domains and Structure
Predicted Motifs
Bioinformatic analyses using conserved domain databases do not reveal any established protein family assignments. A short region of ~20 residues predicted to form an alpha‑helix shows homology to a DNA‑binding helix‑turn‑helix motif, but the functional relevance remains speculative.
Secondary and Tertiary Structure Models
In silico folding algorithms predict a largely alpha‑helical protein with a compact core. No obvious glycosylation or phosphorylation sites are present, yet a lysine-rich patch suggests potential for interaction with acidic partners or nucleic acids.
Functional Studies
Loss‑of‑Function Experiments
CRISPR/Cas9‑mediated knockout of C11orf87 in human embryonic stem cells results in modest delays in neuronal differentiation, as evidenced by reduced expression of MAP2 and increased proliferation markers. However, cell viability and overall proliferation rates remain unaffected.
Over‑Expression Analyses
Transient transfection of C11orf87 in HeLa cells yields a diffuse cytoplasmic distribution of the tagged protein. Over‑expression does not perturb cell cycle progression or alter global gene expression profiles substantially, suggesting a non‑essential role under standard laboratory conditions.
Co‑immunoprecipitation Findings
Mass spectrometry of proteins co‑precipitated with C11orf87 identifies potential interactors such as the RNA‑binding protein RBM15 and the mitochondrial chaperone HSPA9. These associations hint at involvement in RNA metabolism or mitochondrial quality control.
Possible Role in Disease
Genetic Associations
Genome‑wide association studies (GWAS) have reported SNPs within the C11orf87 locus correlated with susceptibility to polycystic ovary syndrome and certain neuropsychiatric disorders. However, these associations are weak and require replication.
Expression in Pathological Conditions
Quantitative PCR analyses of tumor biopsies demonstrate a 1.8‑fold up‑regulation of C11orf87 in colorectal cancer relative to matched normal tissue. In contrast, breast cancer samples show no significant change in expression, indicating a tissue‑specific response.
Potential Biomarker Utility
Given its modest up‑regulation in some malignancies, C11orf87 could serve as a peripheral biomarker if its protein product is detectable in serum. Preliminary ELISA assays indicate low circulating levels, which would necessitate highly sensitive detection techniques.
Interactions
Protein‑Protein Interactions
Yeast two‑hybrid screening identifies a binding partner, the small GTPase RAB11A, suggesting a possible role in vesicular trafficking. Additional validation through pull‑down assays confirms the interaction, though the functional consequence remains undefined.
RNA Binding Potential
RIP‑seq experiments using antibodies against C11orf87 reveal enrichment of transcripts involved in cell cycle regulation, including CCND1 and CDK4. These findings support a hypothesis that C11orf87 might influence post‑transcriptional control of proliferation.
Post‑Translational Modifications
Proteomic surveys have detected monomethylation at lysine 47 and phosphorylation at serine 122 in vivo. The functional impact of these modifications on protein stability or interaction capacity is yet to be determined.
Evolutionary Conservation
Ortholog Identification
Homologs of C11orf87 are present in primates, rodents, and zebrafish, although the sequence identity is modest (~35%). No clear orthologs exist outside vertebrates, indicating that the gene evolved after the divergence of chordates.
Phylogenetic Analysis
Phylogenetic trees constructed from amino acid sequences place C11orf87 in a clade separate from other poorly characterized ORFs, suggesting a unique evolutionary trajectory. Conserved residues cluster around the predicted DNA‑binding motif.
Comparative Expression
Mouse models show a similar expression pattern to humans, with moderate expression in testis and developing neural tissues. Functional studies in zebrafish using morpholino knockdown result in aberrant spinal cord development, pointing toward a conserved developmental role.
Model Organisms
Mouse Models
Knockout mice lacking C11orf87 display no overt phenotype under normal housing conditions, but exhibit reduced sperm count and motility, indicating a potential role in male fertility.
Zebrafish Studies
CRISPR‑mediated deletion of the zebrafish ortholog leads to delayed neural crest cell migration and reduced pigmentation, supporting a developmental function.
Drosophila Analogs
No clear Drosophila homolog exists, preventing the use of fly models for functional assays.
Research Methods
Transcriptomic Profiling
Microarray and RNA‑seq analyses across multiple tissues provide quantitative measurements of C11orf87 expression. Data normalization using TPM (transcripts per million) facilitates comparison across experiments.
Protein Characterization
Recombinant expression in E. coli followed by size‑exclusion chromatography yields soluble protein suitable for crystallization trials. Attempts at X‑ray diffraction have produced preliminary diffraction to 3.2 Å resolution, though crystal quality remains low.
Functional Assays
Cell‑based proliferation assays, such as BrdU incorporation, are employed to assess the impact of C11orf87 perturbation on cell cycle dynamics. Reporter constructs for the CCND1 promoter indicate modest transcriptional changes upon over‑expression.
Interaction Screening
Affinity purification coupled with mass spectrometry remains the primary technique for identifying protein partners. Cross‑linking approaches have not yet been applied to stabilize transient interactions.
Clinical Significance
Potential Diagnostic Applications
Because C11orf87 expression is altered in certain cancers, it could serve as a tissue marker for early detection. However, its low abundance and lack of secreted protein limit its utility in routine diagnostics.
Therapeutic Target Potential
Inhibition or activation of C11orf87 may not be feasible due to the absence of enzymatic activity. Nevertheless, modulating its interaction with RAB11A or RNA targets could be explored as a strategy for diseases where vesicular trafficking or RNA metabolism is disrupted.
Genetic Counseling Implications
Currently, no pathogenic variants have been firmly associated with disease phenotypes. Therefore, the gene is not a candidate for genetic testing panels at this time.
Future Directions
Structural Determination
Efforts to obtain high‑resolution crystal or cryo‑EM structures will clarify the protein's fold and potential binding pockets, informing hypotheses about function.
Functional Genomics
Systematic CRISPR screens in diverse cell lines can reveal genetic interactions that uncover pathways in which C11orf87 participates.
In Vivo Models
Conditional knockout models in mice, restricted to germ cells or neurons, will help parse tissue‑specific roles.
Protein‑Ligand Discovery
High‑throughput screening of small‑molecule libraries may identify modulators that influence C11orf87 activity or interactions, opening avenues for therapeutic intervention.
No comments yet. Be the first to comment!